Developer of innovative microbiome-based therapeutics designed to prevent and treat cancer, IBD and topical diseases that stem from dysbiosis. The company's therapeutics discover and validate proprietary bacterial targets, develop rationally designed phage therapies that seek and destroy harmful bacteria in microbiome-related diseases, enabling medical practitioners to eradicate harmful bacteria in chronic diseases.
100MM - 500MM
7 Pinhas Sapir Street
Ness Ziona, HaMerkaz 7414002
Top 10 Holders of BiomX Inc Warrant 2019-16.10.24 on BiomX
Top 10 Holders of BiomX Inc.
Top 10 Holders of BiomX Inc. Units Cons of 1 Sh + 1 Wt 10.24
Ownership data is sourced through FactSet.
Stock Market Data
Market Data copyright © 2020 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by